Related Experiment Video

Updated: Jun 10, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Inhibition of epithelial to mesenchymal transition in metastatic breast carcinoma cells by c-Src suppression

Xiang Liu1, Renqing Feng

  • 1Peking University, Beijing, China.

Acta Biochimica Et Biophysica Sinica
|August 14, 2010
PubMed

Insights

Suppressing c-Src kinase activity in breast cancer cells inhibits epithelial to mesenchymal transition (EMT). This targeted approach impacts cell migration and key EMT markers, offering potential therapeutic strategies for breast carcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Aberrant activation of c-Src kinase is implicated in tumor progression.
  • Epithelial to mesenchymal transition (EMT) is a critical process in cancer metastasis.

Purpose of the Study:

  • To investigate the role of c-Src suppression in regulating EMT in human breast carcinoma cells.
  • To determine the effects of c-Src inhibition on EMT markers and transcription factors.

Main Methods:

  • Utilized PP2 (a Src-family kinase inhibitor) and small interfering RNA (siRNA) to suppress c-Src in MCF-7 and MDA-MB-231 cells.
  • Assessed cell migration using wound-healing assays.
  • Evaluated transcription and protein levels of EMT markers and transcription factors via reverse transcription-PCR and Western blot analysis.

Main Results:

  • c-Src suppression reversed the mesenchymal phenotype in MDA-MB-231 cells.
  • E-cadherin expression was upregulated, while vimentin was downregulated in response to c-Src suppression.
  • Downregulation of transcription factors Slug and SIP1 was observed, while Twist levels remained unchanged.

Conclusions:

  • c-Src suppression effectively inhibits EMT in breast carcinoma cells.
  • The inhibition of EMT by c-Src suppression occurs through the regulation of specific transcription factors.
  • These findings suggest c-Src as a potential therapeutic target for managing breast cancer metastasis.

More Related Videos

Induction and Analysis of Epithelial to Mesenchymal Transition10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...